Home
»çÀÌÆ®¸Ê
Contact Us
Eng
¼¾ÅͼҰ³
¿¬±¸¿µ¿ª
¿¬±¸È°µ¿
¿¬±¸½ÇÀû
ÀÚ·á½Ç
°Ô½ÃÆÇ
×
¼¾ÅͼҰ³
Àλ縻
¼³¸³¸ñÀû
¿¬Çõ
Á¶Á÷µµ
Âü¿©¿¬±¸Áø
½Ã¼³ ¹× Àåºñ
¿À½Ã´Â ±æ
¿¬±¸¿µ¿ª
ÀÓ»ó¾à¹°À¯Àüü¿¬±¸ºÎ
ºÐÀھ๰À¯Àüü¿¬±¸ºÎ
¾à¹°À¯Àüü¿¬±¸ Áö¿øºÎ
¿¬±¸È°µ¿
¿¬±¸»ç¾÷
¿¬±¸°³¹ß
¿¬±¸Çù·ÂÁö¿ø
Àη¾缺
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
ÀÚ·á½Ç
º¸µµÀÚ·á
»çÁøÀÚ·á
°ü·Ã»çÀÌÆ®
°Ô½ÃÆÇ
Çà»çÀÏÁ¤
°øÁö»çÇ×
¼¾ÅͼҽÄ
Çаè¼Ò½Ä
Contact Us
Eng
³í¹®½ÇÀû
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
Áö¿ø°úÁ¦º° :
¼±ÅÃÇϱâ
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, ¼ö¼Ûü
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM, ¿¬±¸±³¼ö
RCTC
RCTC, BMRC
¿¬µµº° :
¼±ÅÃÇϱâ
2015-International
2015-Domestic
2014-International
2014-Domestic
2013-International
2013-Domestic
2012-International
2012-Domestic
2011-International
2011-Domestic
2010-International
2010-Domestic
2009-International
2009-Domestic
2008-International
2008-Domestic
2007-International
2007-Domestic
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
¸ðµÎº¸±â
·
Shin JG, Park JY, Kim MJ, Shon JH, Yoon YR, Cha IJ, Lee SS, Oh SW, Kim SW, Flockhart DA.
Inhibitory effects of tricyclicantidepresants (TCAs) on human cytochrome P450 enzymes in vitro : Mechanism of drug interaction between TCAs and phenytoin()
Drug Metab Dispos, 2002, 30/1102~1107 [
LINK
]
2003-International
·
Nikoloff D, Shim JC, Fairchild M, Patten N, Fijal BA, Koch WH, MacPherson A, Flockhart D, Yoon YR, Yoon JS, Kim YH, Shin JG.
Association Between CYP2D6 Genotype and Tardive Kyskinesia in Korean Schizophrenics()
The Pharmacogenomics J, 2002, 2/400~407 [
LINK
]
2003-International
·
Shon JH, Yoon YR, Kim KA, Lim YC, Lee KJ, Park JY, Cha IJ, Flockhart DA, Shin JG.
Effect of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans()
Pharmacogenetics, 2002, 12/111~119 [
LINK
]
2003-International
·
Kim KA, Shon JH, Park JY, Yoon YR, Kim MJ, Yun DH, Kim MK, Cha IJ, Hyun MH, Shin JG.
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19()
Clin Pharmacol Ther, 2002, 9/72~90 [
LINK
]
2003-International
·
Desta Z, Zhao X, Shin JG, Flockhart DA.
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism()
Clin Pharmacokinet, 2002, 41/913~958 [
LINK
]
2003-International
·
Liu KH, Sung HJ, Lee HK, Song BH, Ihm YB, Kim K, Lee HS, Kim JH.
Dermal pharmacokinetics of the insecticide furathiocarb in Sprague-Dawley rats()
Pest Manag Sci, 2002, 58/57~62 [
LINK
]
2003-International
·
Liu KH, Rhee SK, Kim JH.
Structural Investigation of Pyribenzoxim Using X-ray Crystallography()
Bull Kor Chem Soc, 2002, 23/1042~1044 [LINK ]
2003-Domestic
·
Keum YS, Liu KH, Seo JS, Kim JH, Kim K, Kim YH, Kim PJ.
Dissipation of foliar residues of diafenthiuron and its metabolites()
Bull Environ Contam Toxicol, 2002, 68/845~821 [
LINK
]
2003-International
·
Seo JS, Liu KH, Chung KH, Shin JS, Kim JH.
Bioconcentration and depuration of pyribenzoxim in common carp (Cyprinus carpio)()
Bull Environ Contam Toxicol, 2002, 68/617~622 [
LINK
]
2003-International
·
Junn E, Lee SS, Suhr UT, Mouradian MM.
Parkin Accumulation in Aggresomes Due to Proteasome Impairment()
J Biol Chem, 2002, 277/47870~47877 [
LINK
]
2003-International
[prev]
21
22
23
24
25
26
27
28
29
30
[Next]
Á¦¸ñ
ÀúÀÚ¸í
Áö¿ø°úÁ¦